Your browser doesn't support javascript.
loading
Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: two case reports.
Grossi, Valentina; Infantino, Maria; Manfredi, Mariangela; Basile, Umberto; Gulli, Francesca; Marino, Mariapaola; Li Gobbi, Francesca; Damiani, Arianna; Atzeni, Fabiola; Benucci, Maurizio.
Afiliação
  • Grossi V; Immunology and Allergology Laboratory Unit, San Giovanni di Dio Hospital, Via Torregalli 3, 50143 Florence, Italy, Phone: +39 055 6932502, Fax: +39 055 6932289.
  • Infantino M; Immunology and Allergology Laboratory Unit, San Giovanni di Dio Hospital, Florence, Italy.
  • Manfredi M; Immunology and Allergology Laboratory Unit, San Giovanni di Dio Hospital, Florence, Italy.
  • Basile U; Area Diagnostica di Laboratorio, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00164 Rome, Italy.
  • Gulli F; Dipartimento di Medicina di Laboratorio, Ospedale Madre Giuseppina Vannini, Rome, Italy.
  • Marino M; Istituto di Patologia Generale, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Li Gobbi F; Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Damiani A; Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy.
  • Atzeni F; Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy.
  • Benucci M; Rheumatology Unit, University of Messina, Messina, Italy.
Clin Chem Lab Med ; 58(4): e105-e108, 2020 03 26.
Article em En | MEDLINE | ID: mdl-31665114

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Certolizumab Pegol / Adalimumab / Anticorpos Tipo de estudo: Diagnostic_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Certolizumab Pegol / Adalimumab / Anticorpos Tipo de estudo: Diagnostic_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article